Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,616.50
Bid: 1,582.00
Ask: 1,695.00
Change: 0.00 (0.00%)
Spread: 113.00 (7.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end flat between Asia worries, British re-opening cheer

Mon, 17th May 2021 09:43

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Asia restrictions, China data weigh

* Kinnevik jumps to top of STOXX 600

* Spain's Telefonica gains as it seeks buyers for delivery
arm

* Sanofi, GSK gain as COVID-19 vaccine shows immune response
(Updates with market close)

By Shashank Nayar and Sruthi Shankar

May 17 (Reuters) - European stocks ended flat on Monday as
underwhelming Chinese data and caution over the spread of a
COVID-19 variant outweighed optimism on the reopening of the
British economy, while Sweden's Kinnevik surged and was the top
performer.

The pan-European STOXX 600 index ended flat with
travel and leisure stocks being the top losers, down
2.3%, while telecommunication stocks jumped the most,
led by gains in Spanish telecom firm Telefonica

Dampening sentiment was data showing that China's factories
slowed their output growth in April and retail sales
significantly missed expectations as officials warned of new
problems affecting the economic recovery.

Meanwhile, fresh restrictions across Asia following a new
wave of COVID-19 cases and concerns over the spread of a
fast-spreading coronavirus variant first identified in India
overshadowed optimism on UK's economic reopening.

"Airlines are on the back foot once again today, with
optimism over the reopening of international travel proving
short-lived given concerns over the growth of the Indian COVID
variant," said Joshua Mahony, senior market analyst at IG.

"Unfortunately, the risks posed by this latest strain also
raise questions around those same businesses that have just
found reprieve from lockdown restrictions, with pub and
restaurant chains all on the back foot despite the resumption of
indoor dining," added Mahony.

Britain's domestically focused mid-cap index dropped
0.6%, with restaurant and pub operator SSP Group and
airlines Easyjet and Wizz Air Holdings being
the top drags.

Irish airline Ryanair fell 2.8% after reporting a
record annual after-tax loss, as it said there were signs the
recovery had begun.

European stocks have performed well so far and surged to
all-time highs this month, with the STOXX 600 up nearly 11% so
far this year as economic recovery prospects and strong earnings
drew buyers of equities.

The European Union has agreed to a partial truce with the
United States in a dispute over metal tariffs imposed by former
President Donald Trump and to start discussions on global
overcapacity and China's "trade-distorting" policies.

Mining stocks gained 0.9%.

In corporate news, Sweden's Kinnevik jumped 8.5%
to the top of the STOXX 600 index after the company transferred
its stake in online fashion retailer Zalando to
shareholders.

Spanish telecoms group Telefonica gained 3.5% as it
is seeking buyers for its logistics and express-delivery unit
Zeleris, a source familiar with the offer said on Monday, amid a
months-long boom in the business as COVID-19 pushes people to
shop online.

Drugmakers Sanofi and GlaxoSmithKline
jumped 1% and 0.7% respectively after their experimental
COVID-19 vaccine showed a robust immune response in early-stage
clinical trial results, enabling them to move to a late-stage
study.
(Reporting by Sruthi Shankar and Shashank Nayar in Bengaluru;
Editing by Subhranshu Sahu and Dan Grebler)

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.